Terazosin Capsule
Product Images NDC 72162-1702

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 72162-1702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621702)

Label for Terazosin Capsules USP, 10 mg strength, containing Terazosin Hydrochloride equivalent to 10 mg Terazosin per capsule. The label indicates a package size of 1000 capsules, labeled by Bryant Ranch Prepack and manufactured by Jubilant Cadista Pharmaceuticals Inc. It includes storage instructions and a barcode with NDC 72162-1702-0.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure of Terazosin Hydrochloride showing its molecular arrangement with functional groups and rings, reflecting the active ingredient in the Terazosin 10 mg capsule product.*

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

This image contains two line graphs comparing placebo and Terazosin. The left graph shows the mean change in total symptom score from baseline over 0 to 3 months for placebo (N=55) and Terazosin (N=54). The right graph displays the mean increase in peak flow rate (mL/sec) from baseline over the same period for placebo (N=54) and Terazosin (N=52). Error bars indicate variability in the data.*

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

A line graph depicting the mean change from baseline over a 30-month period. The x-axis represents months from 0 to 30, and the y-axis shows the mean change from baseline ranging from 0 to -7. Data points connected by a line show a downward trend with significance indicated at multiple time points.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

A line graph depicting the mean change from baseline over time in months. The y-axis shows mean change values, and the x-axis represents months from 0 to 30. Data points are plotted with error bars, with several points marked by asterisks indicating statistical significance. The graph likely presents longitudinal data related to the product Terazosin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.